XRZ

N-[(3-chloro-4-cyanophenyl)methyl]-2-{6-[1-(methoxyacetyl)piperidin-4-yl]-4-oxoquinazolin-3(4H)-yl}-N-methylacetamide

Created:	2023-06-08
Last modified:	2024-12-18

Find Related PDB Entry
1 entries where XRZ is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	65
Chiral Atom Count	0
Bond Count	68
Aromatic Bond Count	12

2D diagram of XRZ

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-[(3-chloro-4-cyanophenyl)methyl]-2-{6-[1-(methoxyacetyl)piperidin-4-yl]-4-oxoquinazolin-3(4H)-yl}-N-methylacetamide
Systematic Name (OpenEye OEToolkits)	~{N}-[(3-chloranyl-4-cyano-phenyl)methyl]-2-[6-[1-(2-methoxyethanoyl)piperidin-4-yl]-4-oxidanylidene-quinazolin-3-yl]-~{N}-methyl-ethanamide
Formula	C₂₇ H₂₈ Cl N₅ O₄
Molecular Weight	521.995
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(COC)N1CCC(CC1)c1ccc2N=CN(CC(=O)N(C)Cc3ccc(C#N)c(Cl)c3)C(=O)c2c1
SMILES	CACTVS	3.385	COCC(=O)N1CCC(CC1)c2ccc3N=CN(CC(=O)N(C)Cc4ccc(C#N)c(Cl)c4)C(=O)c3c2
SMILES	OpenEye OEToolkits	2.0.7	CN(Cc1ccc(c(c1)Cl)C#N)C(=O)CN2C=Nc3ccc(cc3C2=O)C4CCN(CC4)C(=O)COC
Canonical SMILES	CACTVS	3.385	COCC(=O)N1CCC(CC1)c2ccc3N=CN(CC(=O)N(C)Cc4ccc(C#N)c(Cl)c4)C(=O)c3c2
Canonical SMILES	OpenEye OEToolkits	2.0.7	CN(Cc1ccc(c(c1)Cl)C#N)C(=O)CN2C=Nc3ccc(cc3C2=O)C4CCN(CC4)C(=O)COC
InChI	InChI	1.06	InChI=1S/C27H28ClN5O4/c1-31(14-18-3-4-21(13-29)23(28)11-18)25(34)15-33-17-30-24-6-5-20(12-22(24)27(33)36)19-7-9-32(10-8-19)26(35)16-37-2/h3-6,11-12,17,19H,7-10,14-16H2,1-2H3
InChIKey	InChI	1.06	CSGIAQJITLUEOL-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	122603637

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.